STAT3 inhibitor

· MD Anderson Cancer Center

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for STAT3 inhibitor, covering 2013-02-12 to 2013-02-12. Get the full timeline:

Most recent: Clinical Trial Update: STAT3 Inhibitor for Solid Tumors [Phase 1]